A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis.S R Muthuramalingam, Trivadi S. Ganesan, Andrew D. Blann et al.|PubMed|2011Cited by 7